NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics' Prolaris® Test as an 'Advanced Tool' Recommended for Prognostic Assessment
December 09, 2024 08:00 ET
|
Myriad Genetics, Inc.
Myriad Genetics announced Prolaris prostate cancer prognostic test is classified by the NCCN as an advanced tool in the fight against prostate cancer.
Correction: AUA Announces 2025 Distinguished Awards Recognizing Top Urologists
December 04, 2024 14:03 ET
|
American Urological Association
BALTIMORE, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) announced today the list of 2025 award recipients recognizing top urologists in the field. The winners will be...
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)
October 17, 2024 06:45 ET
|
Teleflex Incorporated
• Barrigel™ rectal spacer provides high quality rectal spacing, enabling low dose to the rectum during prostate cancer radiation therapy, with an excellent toxicity and safety profile; and low...
Verana Health Announces Launch of Qdata® BPH
October 01, 2024 09:00 ET
|
Verana Health, Inc.
SAN FRANCISCO, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), today...
Comprehensive Urology Studies ED Injections with Shockwave Therapy for Penile Girth Enhancement
September 23, 2024 15:34 ET
|
Comprehensive Urology
Comprehensive Urology of Los Angeles studies STUD Protocol for male enhancement in survivors of prostate cancer during Prostate Cancer Awareness Month.
Koelis Announces Partnership and Initial Experience with DeepHealth for AI-powered Prostate MRI Interpretation and Guidance in Fusion Biopsy
September 20, 2024 09:07 ET
|
Koelis
Koelis finalizes partnership with Deep Health for AI-powered prostate MRI interpretation and guidance in fusion biopsy for prostate cancer.
The National Civil Rights Museum Hosts Catalyst for Change Panel on Prostate Cancer Health Inequities in Black Men
September 10, 2024 16:22 ET
|
National Civil Rights Museum
Memphis, TN, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The National Civil Rights Museum (NCRM) is proud to present "Tackling Prostate Cancer Disparities in Black Men" as part of its Catalyst for Change...
[Latest] US Endoscopy Devices Market Size/Share Worth USD 12.8 Billion by 2033 at a 6.3% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
August 07, 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “US Endoscopy Devices Market Size, Trends and Insights By Type (Endoscopes,...
United States Urology KOLs Fair-Market Value Compensation Rates Report: An Independent Reference for Negotiations with Thought Leaders (KOLs) and Healthcare Providers (HCPs)
July 10, 2024 05:13 ET
|
Research and Markets
Dublin, July 10, 2024 (GLOBE NEWSWIRE) -- The "Fair-Market Value Compensation Rates for Urology KOLs - United States" report has been added to ResearchAndMarkets.com's offering. Thought Leader...
Advanced MedTech Announces Leadership Transition & Reports Record Revenues for FY2024
July 01, 2024 21:00 ET
|
Advanced MedTech
Singapore, July 02, 2024 (GLOBE NEWSWIRE) -- Abel Ang retires as Group Chief Executive Officer after a decade and will continue to serve on the Board of DirectorsAchieved record global revenues of...